Trials / Recruiting
RecruitingNCT06773182
Assessing Interventions of Diet in IBD
Understanding Patient's Barriers and Perceived Benefits Through Adherence to Nutritional Interventions in IBD: a Preliminary Study.
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 45 (estimated)
- Sponsor
- McMaster University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
In this study, we are trying to learn how certain diets affect people with inflammatory bowel disease (IBD). We want to understand what makes it hard or easy for them to stick to different eating plans, like intermittent fasting, the Mediterranean diet, and the Low FODMAP diet. By finding out how these diets help with symptoms and which ones are easier to follow, we hope to improve the quality of life for people with IBD.
Detailed description
This study aims to explore the impact of specific dietary interventions on individuals living with inflammatory bowel disease (IBD). By examining dietary patterns such as intermittent fasting, the Mediterranean diet, and the Low FODMAP diet, we seek to identify barriers to adherence and facilitators that make these eating plans sustainable. Additionally, we aim to evaluate the perceived benefits of these diets in managing IBD symptoms and their influence on overall quality of life. The findings will provide valuable insights to develop patient-centered nutritional strategies that enhance adherence and therapeutic outcomes in IBD care.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Intermittent Fasting Intervention | A 14:10 intermittent fasting regimen, where participants fast for 14 hours and consume all meals within a 10-hour eating window daily. |
| OTHER | Mediterranean Diet Intervention | A diet emphasizing whole grains, fruits, vegetables, olive oil, lean proteins, and minimizing processed foods. |
| OTHER | Low FODMAP Diet Intervention | A diet limiting fermentable oligosaccharides, disaccharides, monosaccharides, and polyols to manage gastrointestinal symptoms. |
Timeline
- Start date
- 2025-04-01
- Primary completion
- 2026-04-01
- Completion
- 2027-01-01
- First posted
- 2025-01-14
- Last updated
- 2025-06-26
Locations
3 sites across 1 country: Canada
Source: ClinicalTrials.gov record NCT06773182. Inclusion in this directory is not an endorsement.